Study of How Advanced Esophageal Cancer Spreads After Surgery
Part of Cancer, Digestive system clinical trials.
This research examines tissue samples from patients who had surgery to remove advanced esophageal cancer in the neck or chest area. The study aims to understand how the cancer invaded surrounding tissues, which may help doctors better treat similar patients in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had esophageal cancer (squamous cell type) in your neck or upper chest
- Your cancer was stage T2 or T3 (medium to advanced size) before surgery
- You underwent a specific type of surgical removal called McKeown esophagectomy
- You had only one main tumor (not multiple separate cancers)
- You have complete medical records and tissue samples available from your surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment plan that combines immunotherapy with chemotherapy before possible endoscopic surgery. It is for people with a specific type of esophageal cancer that has not been treated before and is either potentially removable or not suitable for standard surgery.
This study uses advanced genetic and imaging tests to monitor how esophageal cancer evolves during treatment. It aims to better understand the disease and guide care for people before and after surgery or on first-line immunotherapy.
This trial tests whether giving immunotherapy after surgery can help prevent cancer from returning in patients with esophageal squamous cell carcinoma. It is for people who have already received chemotherapy and immunotherapy before surgery and had surgery to remove the cancer, but still had some cancer cells found in the removed tissue.
This trial looks at how well the tumor responded to chemotherapy or radiation before surgery, to see if that can help doctors decide next steps like additional treatment. It may help people with esophageal squamous cell cancer who had the tumor removed completely after initial therapy.
This trial tests a new way to remove lymph nodes during surgery for esophageal cancer after you've already had chemo and immunotherapy. The goal is to see if guiding lymph node removal with a special technique helps improve outcomes.
This trial compares the current standard treatment (chemotherapy and radiation) with a newer approach that combines chemotherapy and immunotherapy before surgery for esophageal cancer. Participation may help determine if this new combination is more effective for you.
Hear when a new Infiltration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.